MET and KRAS gene amplification mediates acquired resistance to MET tyrosine kinase inhibitors

被引：0

作者：

Ghiso, E. ^{[1
]}

Cepero, V. ^{[2
,3
]}

Sierra, J. R. ^{[2
,3
]}

Corso, S. ^{[1
]}

Casorzo, L. ^{[1
]}

Perera, T. ^{[4
]}

Comoglio, P. M. ^{[1
]}

Giordano, S. ^{[1
]}

机构：

[1] IRCC, Candiolo Turin, Italy

[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[3] Ontario Canc Inst, Univ Hlth Network, Toronto, ON M4X 1K9, Canada

[4] Ortho Biotech, Oncol Res & Dev, Beerse, Belgium

来源：

EJC SUPPLEMENTS | 2010年 / 8卷 / 07期

关键词：

D O I：

10.1016/S1359-6349(10)72019-X

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：100 / 100

页数：1

共 50 条

[21] KRAS mutation in the primary or acquired resistance of Chinese NSCLC to EGFR tyrosine kinase inhibitors [J].

Chen, H. ;

Wu, Y. ;

Zhang, X. ;

Chen, Z. ;

Guo, A. ;

Cheng, H. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

[22] Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer [J].

Yao, Yu ;

Yang, Huaping ;

Zhu, Bo ;

Wang, Song ;

Pang, Jiaohui ;

Wu, Xiaoying ;

Xu, Yang ;

Zhang, Junli ;

Zhang, Jinfeng ;

Ou, Qiuxiang ;

Tian, Hui ;

Zhao, Zheng .

RESPIRATORY RESEARCH, 2023, 24 (01)

[23] Mutations in the MET tyrosine kinase domain and resistance to tyrosine kinase inhibitors in non-small-cell lung cancer [J].

Yu Yao ;

Huaping Yang ;

Bo Zhu ;

Song Wang ;

Jiaohui Pang ;

Xiaoying Wu ;

Yang Xu ;

Junli Zhang ;

Jinfeng Zhang ;

Qiuxiang Ou ;

Hui Tian ;

Zheng Zhao .

Respiratory Research, 24

[24] Effect of MET tyrosine kinase inhibitors on MET amplified gastro-esophageal cancer cells [J].

Kim, Jin-Soo ;

Hong, Sungyoul ;

Kim, Mi Young .

CANCER RESEARCH, 2022, 82 (12)

[25] MET Receptor Tyrosine Kinase [J].

Faoro, Leonardo ;

Cervantes, Gustavo M. ;

El-Hashani, Essam ;

Salgia, Ravi .

JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (11) :S1064-S1065

[26] Mechanisms of acquired resistance to MET tyrosine kinase inhibitors (TKIs) in MET exon 14 (METex14) mutant non-small cell lung cancer (NSCLC). [J].

Awad, Mark M. ;

Bahcall, Magda ;

Sholl, Lynette M. ;

Wilson, Frederick Hugh ;

Paweletz, Cloud ;

Capelletti, Marzia ;

Leonardi, Giulia Costanza ;

Watanabe, Masayuki ;

Baba, Hideo ;

Chambers, Emily S. ;

Redig, Amanda J. ;

Nishino, Mizuki ;

VanderLaan, Paul A. ;

Costa, Daniel Botelho ;

Imamura, Yu ;

Janne, Pasi A. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)

[27] Novel targets mediating resistance to EGFR/c-Met tyrosine kinase inhibitors in NSCLC [J].

Jacobs, Ryan ;

Fong, Jason ;

Bomgarden, Ryan ;

Rogers, John ;

Puri, Neelu .

CANCER RESEARCH, 2012, 72

[28] Mechanisms of Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14 Mutant Non-Small Cell Lung Cancer [J].

Recondo, G., Jr. ;

Bahcall, M. ;

Sholl, L. ;

Leonardi, G. ;

Ricciuti, B. ;

Nguyen, T. ;

Venkatraman, D. ;

Lamberti, G. ;

Umeton, R. ;

Janne, P. ;

Awad, M. .

JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) :S285-S285

[29] Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer [J].

Suda, Kenichi ;

Murakami, Isao ;

Katayama, Tatsuya ;

Tomizawa, Kenji ;

Osada, Hirotaka ;

Sekido, Yoshitaka ;

Maehara, Yoshihiko ;

Yatabe, Yasushi ;

Mitsudomi, Tetsuya .

CLINICAL CANCER RESEARCH, 2010, 16 (22) :5489-5498

[30] ACQUIRED RESISTANCE TO ALK TYROSINE KINASE INHIBITORS [J].

Sasaki, T. ;

Ohsaki, Y. ;

Pasi, J. .

ANNALS OF ONCOLOGY, 2012, 23 :80-80

← 1 2 3 4 5 →